PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy

Abstract Background Intravascular large B‐cell lymphoma (IVLBCL) is a rare form of diffuse large B‐cell lymphoma (DLBCL) arising in extranodal sites. PD‐L1 expression of tumor cells has been reported in IVLBCL cells, but its clinicopathological relevance remains to be elucidated. Aims This study was...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yuka Suzuki, Kei Kohno, Kosei Matsue, Ayako Sakakibara, Eri Ishikawa, Satoko Shimada, Kazuyuki Shimada, Seiyo Mabuchi, Taishi Takahara, Seiichi Kato, Shigeo Nakamura, Akira Satou
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2020-07-01
סדרה:	Cancer Medicine
נושאים:	extranodal DLBCL immunohistochemistry intravascular large B‐cell lymphoma PD‐L1 SP142
גישה מקוונת:	https://doi.org/10.1002/cam4.3104
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!